文献速递糖尿病

尿液补体蛋白与2型糖尿病肾病进展及死亡风险

Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2018-08-27

在141例以墨西哥裔美国人为主的2型糖尿病合并蛋白尿性糖尿病肾病队列中,用靶向质谱定量12种尿液补体蛋白,采用时间-事件分析评估其与进展至终末期肾病(ESRD)或死亡的相关性。

要点

  • 尿CD59每翻倍与ESRD风险降低相关(HR 0.50,95%CI 0.29-0.87)。
  • 尿CD59每翻倍与死亡风险降低相关(HR 0.56,95%CI 0.34-0.93)。
  • 尿因子H相关蛋白2每翻倍与死亡风险升高相关(HR 1.61,95%CI 1.05-2.48)。

核心结论

  • 在2型糖尿病合并蛋白尿性DKD人群中,多种尿液补体及补体调节蛋白丰度与进展至ESRD和死亡强烈相关。

研究设计与样本

  • 使用靶向质谱定量141例以墨西哥裔美国人为主的2型糖尿病合并蛋白尿性DKD患者的12种尿液补体蛋白,采用时间-事件分析评估其与进展至ESRD或死亡的相关性。

主要发现

  • 基线中位eGFR为54 mL/min/1.73 m2,尿蛋白肌酐比为2.6 g/g。
  • 调整人口学和临床协变量(包括基线eGFR和蛋白尿)后,尿CD59每翻倍与ESRD风险降低相关(HR 0.50,95%CI 0.29-0.87),与死亡风险降低相关(HR 0.56,95%CI 0.34-0.93)。
  • 尿补体C4和C8每翻倍分别与死亡风险降低相关(HR 0.57,95%CI 0.41-0.79;HR 0.66,95%CI 0.44-0.97)。
  • 在完全调整模型中,尿因子H相关蛋白2每翻倍与死亡风险升高相关(HR 1.61,95%CI 1.05-2.48)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We examined the association of urine complement proteins with progression to end-stage renal disease (ESRD) or death in people with type 2 diabetes and proteinuric diabetic kidney disease (DKD). RESEARCH DESIGN AND METHODS: Using targeted mass spectrometry, we quantified urinary abundance of 12 complement proteins in a predominantly Mexican American cohort with type 2 diabetes and proteinuric DKD (n = 141). The association of urine complement proteins with progression to ESRD or death was evaluated using time-to-event analyses. RESULTS: At baseline, median estimated glomerular filtration rate (eGFR) was 54 mL/min/1.73 m2 and urine protein-to-creatinine ratio 2.6 g/g. Sixty-seven participants developed ESRD or died, of whom 39 progressed to ESRD over a median of 3.1 years and 40 died over a median 3.6 years. Higher urine CD59, an inhibitor of terminal complement complex formation, was associated with a lower risk of ESRD (hazard ratio [HR] [95% CI per doubling] 0.50 [0.29-0.87]) and death (HR [95% CI] 0.56 [0.34-0.93]), after adjustment for demographic and clinical covariates, including baseline eGFR and proteinuria. Higher urine complement components 4 and 8 were associated with lower risk of death (HR [95% CI] 0.57 [0.41-0.79] and 0.66 [0.44-0.97], respectively); higher urine factor H-related protein 2, a positive regulator of the alternative complement pathway, was associated with greater risk of death (HR [95% CI] 1.61 [1.05-2.48]) in fully adjusted models. CONCLUSIONS: In a largely Mexican American cohort with type 2 diabetes and proteinuric DKD, urine abundance of several complement and complement regulatory proteins was strongly associated with progression to ESRD and death.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Vaisar T, Durbin-Johnson B, Whitlock K, et al. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. Diabetes Care. 2018. PMID: 30150236. doi:10.2337/dc18-0699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。